Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,708 | -2,536 | 18,691 | -19,959 | -9,207 |
| Depreciation Amortization | N/A | N/A | N/A | 2,102 | 1,363 |
| Accounts payable and accrued liabilities | 510 | 85 | -2,245 | N/A | N/A |
| Other Working Capital | 1,426 | 425 | -3,149 | -33,933 | -18,285 |
| Other Operating Activity | 2,067 | 924 | -27,000 | 17,640 | 1,702 |
| Operating Cash Flow | $-2,705 | $-1,102 | $-13,703 | $-34,150 | $-24,427 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -184 | -115 |
| Purchase Of Investment | N/A | N/A | N/A | -15,270 | -8,243 |
| Sale Of Investment | N/A | N/A | N/A | 24,007 | 18,895 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $8,553 | $10,537 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 19,781 | 19,781 |
| Other Financing Activity | -108 | 0 | 5,000 | 0 | 0 |
| Financing Cash Flow | $9,892 | $N/A | $5,000 | $19,781 | $19,781 |
| Exchange Rate Effect | N/A | N/A | N/A | 75 | 412 |
| Beginning Cash Position | 7,350 | 7,350 | 16,053 | 38,635 | 38,635 |
| End Cash Position | 14,537 | 6,248 | 7,350 | 32,894 | 44,938 |
| Net Cash Flow | $7,187 | $-1,102 | $-8,703 | $-5,741 | $6,303 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,705 | -1,102 | -13,703 | -34,150 | -24,427 |
| Capital Expenditure | N/A | N/A | N/A | -184 | -115 |
| Free Cash Flow | -2,705 | -1,102 | -13,703 | -34,334 | -24,542 |